Maeva Agapoff

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)
Youssouf Sereme, Cécile Schrimp, Helène Faury, Maeva Agapoff, Esther Lefebvre-Wloszczowski, Yunhua Chang Marchand, Elisabeth Ageron-Ardila, Emilie Panafieu, Frank Blec, Mathieu Coureuil, Eric Frapy, Vassilis Tsatsaris, Stephane Bonacorsi, David Skurnik
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. Nature communications 15 (1) (2024)

Maeva Agapoff.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maeva Agapoff